All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

French SAGhE Study: Long-Term Mortality After Childhood Recombinant Growth Hormone Treatment

By

Carel, Jean-Claude, Ecosse, Emmanuel, Landier, Fabienne, Meguellati-Hakkas, Djamila, Kaguelidou, Florentia, Rey, Grégoire, Coste, Joël

5h ago· 4 min readenInsight

Summary

This preliminary report from the French SAGhE study examines long-term mortality risks in subjects who received recombinant growth hormone (GH) treatment during childhood for isolated growth hormone deficiency or idiopathic short stature. The study investigates the safety and long-term health outcomes of GH treatment, addressing concerns about potential increased mortality risks associated with this therapy.

Source

Twitter / XFrench SAGhE Study: Long-Term Mortality After Childhood Recombinant Growth Hormone Treatmentacademic.oup.com

Key quotes

· 2 pulled
Little is known about the long-term health of subjects treated with GH in childhood
Safety and Appropriateness of Growth hormone treatments
Snippet from the RSS feed
Context:. Little is known about the long-term health of subjects treated with GH in childhood, and Safety and Appropriateness of Growth hormone treatments

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.